A new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging lays the foundation for treating addiction with transcranial magnetic stimulation
In a study investigating the use of transcranial magnetic stimulation (TMS) for drug addiction, researchers at Medical University of South Carolina are the first to demonstrate that the noninvasive brain stimulation technique can dampen brain activity in response to drug cues in chronic alcohol users and chronic cocaine users. The findings are published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Although the last 50 years of clinical and preclinical research have demonstrated that addiction is a brain disease, there are still no neural circuit-based treatments for substance dependence or the brain functions involved in the disorder. “Here, for the first time, we demonstrate that a new non-invasive brain stimulation technique may be the first tool available to fill this critical void in addiction treatment development,” said senior author Colleen Hanlon, PhD.
Elevated brain activity in response to drug cues—referred to as cue reactivity—occurs with many types of drugs, including nicotine, alcohol, marijuana, and cocaine. Cue reactivity also predicts relapse in addiction, so treatment approaches targeting the neural circuitry related to cue reactivity may directly impact cue-induced relapse in patients.
“Therefore, these results have a tremendous potential to impact both basic discovery neuroscience as well as targeted clinical treatment development for substance dependence,” said Dr. Hanlon.
First author of the paper Tonisha Kearney-Ramos, PhD, and colleagues performed two independent studies at the same time, one involving 25 people with cocaine use disorder and the other involving 24 people with alcohol use disorder. The participants received one session of TMS, which targeted magnetic stimulation to circuitry critical for drug-taking behaviors—the ventromedial prefrontal cortex. The real stimulation session was compared against a sham session that mimicked the experience of receiving TMS without actual brain stimulation.
Brain imaging before and after TMS revealed that when alcohol users viewed images of alcohol-related cues, such as a liquor bottle, the single TMS session significantly reduced their drug cue reactivity. The same was true for cocaine users when viewing images of cocaine-related cues.
“Since cue reactivity has previously been associated with abstinence, these studies suggest a common mechanism for treatment effects across disorders, with fMRI serving as a promising neural readout of treatment effects,” said Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
However, it is still unclear if the changes in brain activity observed in the study will translate to reduced drug or alcohol use. The participants did not report any changes in their drug or alcohol craving after TMS. The authors think that repeated sessions of the targeted stimulation may be needed to see changes in self-reported craving. The researchers hope to answer this question in an ongoing clinical trial involving multiple TMS sessions in cocaine users.
In addition to substance abuse, elevated cue-reactivity is a core symptom of many diseases, such as post-traumatic stress disorder, generalized anxiety disorder, traumatic brain injury, smoking, and obesity, said Dr. Hanlon. “Therefore, the treatment described in this manuscript may have implications far beyond the substance abuse field.”
The Latest on: Transcranial magnetic stimulation
via Google News
The Latest on: Transcranial magnetic stimulation
- COVID-19 tracking, rain and soil, free webinars and moreon June 5, 2020 at 1:00 am
With a major research university right in our backyard, a strong military presence and innovative companies throughout the metro region, there’s often a plethora of interesting science and technology ...
- Neuromodulation Market Analysis as per the Latest Coronavirus Impacton June 2, 2020 at 1:09 am
sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on ...
- How 3 smaller medtechs are navigating COVID-19on June 1, 2020 at 9:04 am
Neuronetics, TransEnterix and CVRx are all specialized device makers seeking to maintain operations and win new customers at a time when medtech sales are disrupted and supplies to help resume them ...
- New mental health facility opens in Topekaon May 28, 2020 at 3:40 pm
Mental health care is needed more than ever. Now, Topeka has another place to get treatment. Breakaway TMS just opened up in Topeka, offering psychiatry services and ...
- Non-invasive brain stimulation for posttraumatic stress disorder: a systematic review and meta-analysison May 28, 2020 at 5:27 am
The present review followed the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) 24. Four English bibliographic databases including PubMed, PsycINFO, Web of Science and ...
- Nexstim Oyj - Managers' Transactionson May 25, 2020 at 5:11 pm
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD), ...
- Federal grant to help UArizona scientist focus on memory loss treatmentson May 19, 2020 at 7:30 am
Here's how an Arizona researcher hopes to develop a treatment for memory loss and cognitive impairment. #Phoenix ...
- Researchers report outcome predictors of repetitive transcranial magnetic stimulation for MDDon May 15, 2020 at 11:02 am
Measures of depression symptom severity, employment status and refractoriness appeared to predict outcomes of repetitive transcranial magnetic stimulation, or rTMS, among individuals with major ...
- Neuronetics Recognizes Critical Health Professionals During Mental Health Awareness Monthon May 6, 2020 at 5:00 pm
Since Neuronetics received FDA clearance in 2008 for its NeuroStar® Advanced Therapy transcranial magnetic stimulation (TMS) system — a proven, non-drug, non-invasive depression option for ...
via Bing News